Transfusions of CPDA-1 red blood cells stored for up to 28 days decrease donor exposures in very low-birth-weight premature infants

被引:39
作者
da Cunha, DHF [1 ]
dos Santos, AMN [1 ]
Kopelman, BI [1 ]
Areco, KN [1 ]
Guinsburg, R [1 ]
Peres, CD [1 ]
Chiba, AK [1 ]
Kuwano, ST [1 ]
Terzian, CCN [1 ]
Bordin, JO [1 ]
机构
[1] Univ Fed Sao Paulo, Dept Pediat, Div Neonatol Med, Hematol & Transfus Med Serv,Dept Biostat, Sao Paulo, Brazil
关键词
blood donors; erythrocyte transfusion; hyperkalaemia; infant newborn; neonatal anaemia; premature infants;
D O I
10.1111/j.1365-3148.2005.00624.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The goal of this research was to study the safety and the efficacy of transfusing citrate-phosphate-adenine anticoagulant-preservative (CPDA-1) RBC stored for up to 28 days to reduce donor exposures in premature infants. A prospective randomized two-group study was conducted with very low-birth-weight premature infants that received at least one RBC transfusion during hospital stay. Neonates randomly assigned to Group 1 (26 infants) were transfused with CPDA-1 RBC stored for up to 28 days; those assigned to Group 2 (26 infants) received CPDA-1 RBC stored for up to 3 days. Demographic and transfusion-related data were collected. Neonates from both groups showed similar demographics and clinical characteristics. The number of transfusions per infant transfused was 4.4 +/- 4.0 in Group 1 and 4.2 +/- 3.1 in Group 2, and the number of donors per infant transfused was 1.5 +/- 0.8 (Group 1) and 4.3 +/- 3.4 (Group 2), P < 0.001. RBC transfusions containing 29.7 +/- 18.3 mmol L-1 of potassium (RBC stored for up to 28 days) did not cause clinical or biochemical changes and reduced donor exposures by 70.2%, compared to transfusions containing 19.8 +/- 12.3 mmol L-1 of potassium (RBC stored for up to 3 days), P < 0.001. In conclusion, RBC stored for up to 28 days safely reduced donor exposures in premature infants.
引用
收藏
页码:467 / 473
页数:7
相关论文
共 19 条
[1]   The cost of allogeneic red blood cells -: a systematic review [J].
Amin, M ;
Fergusson, D ;
Aziz, A ;
Wilson, K ;
Coyle, D ;
Hébert, P .
TRANSFUSION MEDICINE, 2003, 13 (05) :275-285
[2]  
Engelfriet CP, 2001, VOX SANG, V80, P122, DOI 10.1046/j.1423-0410.2001.00022.x
[3]   Transfusion guidelines for neonates and older children [J].
Gibson, BES ;
Todd, A ;
Roberts, I ;
Pamphilon, D ;
Rodeck, C ;
Bolton-Maggs, P ;
Durbin, G ;
Duguid, J ;
Boulton, F ;
Cohen, H ;
Smith, N ;
McClelland, DBL ;
Rowley, M ;
Turner, G .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 124 (04) :433-453
[4]   Donor exposure rate to transfusion ratio: a better discriminator of improvement in neonatal transfusion practice [J].
Ibojie, J ;
Greiss, M ;
Lloyd, DJ ;
Urbaniak, SJ .
TRANSFUSION MEDICINE, 2003, 13 (05) :287-291
[5]   Safety and efficacy of AS-1 red blood cell use in neonates [J].
Jain, R ;
Jarosz, C .
TRANSFUSION AND APHERESIS SCIENCE, 2001, 24 (02) :111-115
[6]   REDUCING BLOOD-DONOR EXPOSURES IN LOW-BIRTH-WEIGHT INFANTS BY THE USE OF OLDER, UNWASHED PACKED RED-BLOOD-CELLS [J].
LEE, DA ;
SLAGLE, TA ;
JACKSON, TM ;
EVANS, CS .
JOURNAL OF PEDIATRICS, 1995, 126 (02) :280-286
[7]   PROSPECTIVE, RANDOMIZED TRIAL OF THE SAFETY AND EFFICACY OF A LIMITED DONOR EXPOSURE TRANSFUSION PROGRAM FOR PREMATURE NEONATES [J].
LIU, EA ;
MANNINO, FL ;
LANE, TA .
JOURNAL OF PEDIATRICS, 1994, 125 (01) :92-96
[8]   Reduction in red blood cell transfusions using a bedside analyzer in extremely low birth weight infants [J].
Madan A. ;
Kumar R. ;
Adams M.M. ;
Benitz W.E. ;
Geaghan S.M. ;
Widness J.A. .
Journal of Perinatology, 2005, 25 (1) :21-25
[9]   Changing practices of red blood cell transfusions in infants with birth weights less than 1000 g [J].
Maier, RF ;
Sonntag, J ;
Walka, MM ;
Liu, GS ;
Metze, BC ;
Obladen, M .
JOURNAL OF PEDIATRICS, 2000, 136 (02) :220-224
[10]  
Sacher R A, 1989, Transfus Med Rev, V3, P39, DOI 10.1016/S0887-7963(89)70067-5